A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

AbbVie loses bid to block Tennessee 340B law as federal court upholds state statute limiting drugmaker restrictions on contract pharmacies.

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning whether those savings are being used ...

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

The drug discount program is under scrutiny on a variety of fronts ...

AHA urges HHS to block Novo Nordisk's 340B data demand, citing legal and cost concerns for safety-net hospitals and covered entities.

Hospitals and contract pharmacies are not required to pass those savings directly to patients at the pharmacy counter. | ...

The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in a recent Executive Order. The 340B Drug Pricing Program has received a lot ...

There are times when more isn’t better. It’s just more. This is one of those times. Democratic legislators are pushing Senate ...

Advocates for health care providers are urging state lawmakers to pass legislation to prevent drug manufacturers from restricting access to discounted medications through the 340B Drug Pricing ...